What Happened?
Cambridge, MA-based Sherlock-Biosciences Appointed Karen Davies as Chief Development Officer
About the Company
Sherlock Biosciences aims to disrupt molecular diagnostics with better, faster, affordable tests. With our unique Engineering Biology platforms, we are on the cusp of solving challenges ranging from faster pathogen detection and simpler testing for cancer to improved food safety. We envision a world where our products will enable users to make more effective decisions in any environment, whether in hospitals, industrial settings, the developing world, or at home. Our team and founders include Engineering Biology pioneers with world-leading expertise in CRISPR and Synthetic Biology, diagnostic industry veterans, and disease-area authorities. Together, they provide an unparalleled set of capabilities that are transforming molecular diagnostics in clinical and non-clinical settings.
About the Person
Karen Davies is Chief Development Officer at Sherlock Biosciences. Previously, Karen held various senior HR leadership roles in the industry.
Info Source
News
Short Profile